Ardent Equine and Pegasus Orthobiologics Partner to Streamline Orthobiologic Treatments

Ardent Equine, a biotechnology company committed to the advancement of equine healthcare, has teamed up with Pegasus Orthobiologics to streamline the process of orthobiologic treatments and tailor them to meet the specific needs of each equine injury. Pegasus Orthobiologics is a new laboratory service facility specializing in biologic therapies, and their partnership with Ardent Equine will bring together leading equine sports medicine professionals and scientists with the expertise to revolutionize orthobiologic treatments in veterinary medicine.

Veterinarians are increasingly searching for alternative treatment options since the rise of regenerative therapy in both human and animal medicine. Orthobiologics are an effective means of utilizing regenerative medicine for equine patients. However, regenerative medicine needs to be optimized and tailored to each condition since this approach is seldom a one-size-fits-all solution. Multiple studies have shown that a composition tailored to the injury is essential.

The Partnership

Ardent Equine has joined forces with Drs. Phillipe Benoit, Omar Maher, and Lauren Schnabel of Pegasus Orthobiologics to integrate regenerative medicine into veterinary practice. The combined expertise of both organizations will not only aid in streamlining the procedure of orthobiologic treatments but also customize them to meet the specific needs of each injury. The objective of the partnership is to enhance the healing process and significantly improve treatment outcomes.

Autologous Conditioned Serum (ACS) and Elevate Conditioned Serum (ECS) Laboratory Services

Ardent Equine now offers an Autologous Conditioned Serum (ACS) laboratory service in addition to blood-based Elevate Conditioned Serum (ECS). ECS comprises a high volume of final product, offering enough serum for a comprehensive treatment strategy. The service is designed for busy veterinarians, delivering an autologous biologic containing essential growth factors and cytokines such as TGF-β1, IL-1Ra, IL-10, and IL-4 for modulating inflammation and promoting tissue healing.

The Platelet-Rich Plasma (PRP) Challenge

Pegasus Orthobiologics has addressed the critical problem of inconsistent and low-efficacy Platelet-Rich Plasma (PRP) by developing a process that standardizes the leukocyte and platelet concentrations while guaranteeing extremely low red and white blood cell counts. Our groundbreaking technology caters to tailoring platelet concentrations to the specific joint under treatment. Consequently, Pegasus delivers highly effective PRP, transforming a therapy that could be hit-or-miss into a consistently reliable and standardized treatment.

The Long-Term Goals

Besides PRP preparation services, Pegasus Orthobiologics plans to improve and standardize the processing of other orthobiologics, such as ACS. Collaboration with Ardent Equine is a significant stepping stone towards achieving this goal. Grounded in mutual passion for equine welfare and elevating care standards, our partnership provides the highest quality and safest orthobiologics available today.

Conclusion

Orthobiologic treatment provides a revolutionary approach for equine patients’ healing process, and Ardent Equine has joined forces with Pegasus Orthobiologics to streamline this process. Their services aid in tailoring treatments to meet the specific needs of each injury, enhancing the healing process, and significantly improving treatment outcomes. Furthermore, their high-efficacy PRP treatment improves what was once a hit-or-miss therapy into a consistently effective and standardized treatment. Stay informed with the EquiManagement to receive industry news, disease alerts, and vet practice updates delivered to your inbox.

Originally Post From https://equimanagement.com/news/regenerative-medicine-bridging-the-2-horse-capitals-of-the-world/

Regenerative Medicine Bridging the 2 Horse Capitals of the World – EquiManagement